NewEdge Advisors, LLC

Position in INCY — Incyte Corp

CIK 1633516 NEW ORLEANS, LA

Position in INCY

as of Mar 31, 2026 · filed Jun 3, 2026 Compact

Position Value

$1,921,553

+$625,296 QoQ

Shares Held

20,416

+55.6% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 17.589145768025077.ToString("F0")% Shared 0.ToString("F0")% None 82.41085423197492.ToString("F0")%

Healthcare · as of Mar 31, 2026

NewEdge Advisors, LLC holds $33,544,404 across 116 Biotechnology names. INCY ranks #5 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	17,146	$7,656,374
2	REGN	Regeneron Pharmaceuticals, Inc.	7,610	$5,879,790
3	NUVB	Nuvation Bio Inc.	1,031,112	$4,423,470
4	PHAT	Phathom Pharmaceuticals, Inc.	183,000	$2,033,130
5	INCY	Incyte Corp This page	20,416	$1,921,553
6	EXEL	Exelixis, Inc.	33,985	$1,457,616
7	BMRN	Biomarin Pharmaceutical Inc	24,351	$1,375,587
8	INSM	INSMED Inc	6,015	$983,572

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,921,553	20,416	+55.6%	Shares	Sole	2026-06-03
2025-12-31	$1,296,257	13,124	+21.2%	Shares	Sole	2026-02-18
2025-09-30	$918,068	10,825	+9.3%	Shares	Sole	2025-11-17
2025-06-30	$674,598	9,906	-21.4%	Shares	Sole	2025-08-14
2025-03-31	$762,748	12,597	+369.3%	Shares	Sole	2025-05-15
2024-12-31	$185,383	2,684	-61.5%	Shares	Sole	2025-02-13
2024-09-30	$460,849	6,972	-69.8%	Shares	Sole	2024-11-14
2024-06-30	$1,399,533	23,087	+23.9%	Shares	Sole	2024-08-16
2024-03-31	$1,061,408	18,631	+18719.2%	Shares	Sole	2024-05-14
2023-12-31	$6,216	99	-98.8%	Shares	Sole	2024-02-13
2022-12-31	$670,912	8,353	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.